Valuation (67%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 7.26 | 4.76 |
| PEG Ratio (TTM) | 0.01 | -1.06 |
| P/S Ratio (TTM) | 11.05 | 51.83 |
| P/B Ratio (TTM) | 0.98 | 0.94 |
| P/FCF Ratio (TTM) | -2.48 | 18.55 |
| Price to 5YR AVG Earnings Ratio | 38.03 | 27.01 |
| Price to 5YR AVG FCF Ratio | 13.80 | 29.07 |
Profitability (60%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 8.84% | 1.22% |
| ROE (TTM) | 13.67% | 5.36% |
| Net Profit Margin (TTM) | 152.31% | 29.84% |
| ROIC 5YR AVG | 2.42% | 7.74% |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -73.99% | 178.89% | 173.07% |
| Revenue | 14.03% | 188.15% | 165.66% |
| Net Income | -74.67% | 180.51% | 174.02% |
| Cash Flow | -280.27% | 561.77% | 340.39% |
Health (35%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | 1.63 |
| Quick Ratio (TTM) | N/A | 1.59 |
| D/E Ratio (TTM) | 0.51 | 0.72 |
| Interest Coverage (TTM) | 9.76 | 20.65 |
| Piotroski F-Score | 7 | 6 |
| Altman Z-Score | 1.43 | 7.59 |
| LTL to 5YR AVG FCF | 6.61 | 9.29 |
| Shares Outstanding Growth 5YR AVG | 0.01% | -0.94% |